Institutional aids such as the BILH GLP-1RA Conversion Guide present approximate starting points and explicitly state that charts do not replace clinical judgment
Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)
Understanding what semaglutide should look like and recognizing warning signs helps protect you from potential complications including reduced efficacy, unpredictable blood glucose control, or injection site infections
Heres a look at how dosages change over time: Compounded semaglutide is a big step towards personalized medicine
It is administered subcutaneously and supports flexible dosing frequencies, including micro-dosing, multiple weekly injections, or a once-weekly flex titration schedule
